Paresh Jadav
@jadav.bsky.social
Nephrologist
Houston, TX
#NephSky
Houston, TX
#NephSky
Reposted by Paresh Jadav
Reposted by Paresh Jadav
#NephJC at #KidneyWk
🔥🔥We have all sorts of events
🗓️ Friday, a classic: #NephJC night- #NephJCKidney Awards,
@freelyfiltered.bsky.social
live recording + lots of fun
🗓️ Saturday, Nov 8th, 6:30 am- will start the day with a nephro run 🏃🏃
For more info 👇👇
www.nephjc.com
🔥🔥We have all sorts of events
🗓️ Friday, a classic: #NephJC night- #NephJCKidney Awards,
@freelyfiltered.bsky.social
live recording + lots of fun
🗓️ Saturday, Nov 8th, 6:30 am- will start the day with a nephro run 🏃🏃
For more info 👇👇
www.nephjc.com
NephJC
www.nephjc.com
November 5, 2025 at 8:15 PM
#NephJC at #KidneyWk
🔥🔥We have all sorts of events
🗓️ Friday, a classic: #NephJC night- #NephJCKidney Awards,
@freelyfiltered.bsky.social
live recording + lots of fun
🗓️ Saturday, Nov 8th, 6:30 am- will start the day with a nephro run 🏃🏃
For more info 👇👇
www.nephjc.com
🔥🔥We have all sorts of events
🗓️ Friday, a classic: #NephJC night- #NephJCKidney Awards,
@freelyfiltered.bsky.social
live recording + lots of fun
🗓️ Saturday, Nov 8th, 6:30 am- will start the day with a nephro run 🏃🏃
For more info 👇👇
www.nephjc.com
Hi this is Paresh from Houston. No COI.
I don't always read the guidelines, but when I do, it is after the patient has left the clinic! #NephJC
I don't always read the guidelines, but when I do, it is after the patient has left the clinic! #NephJC
October 29, 2025 at 1:04 AM
Hi this is Paresh from Houston. No COI.
I don't always read the guidelines, but when I do, it is after the patient has left the clinic! #NephJC
I don't always read the guidelines, but when I do, it is after the patient has left the clinic! #NephJC
Reposted by Paresh Jadav
17 trials with 955 patients
DAPA-CKD had 4,300 CKD patients one of half dozen CKD #Flozin trial
This is so under studied it is pathetic.
If you are going to change someone whole lifestyle you need to bring receipts
Do better dieticians
#NephJC
DAPA-CKD had 4,300 CKD patients one of half dozen CKD #Flozin trial
This is so under studied it is pathetic.
If you are going to change someone whole lifestyle you need to bring receipts
Do better dieticians
#NephJC
T2a
Seventeen RCTs, including 955 patients, were included in the systematic review and 14 were included in at least one outcome-specific meta-analysis. #NephJC
Seventeen RCTs, including 955 patients, were included in the systematic review and 14 were included in at least one outcome-specific meta-analysis. #NephJC
October 15, 2025 at 1:29 AM
Reposted by Paresh Jadav
T3a
Chimerism is closer to being mainstream. This trial moves immune tolerance from a "Greek legend" to a reproducible strategy for select pts. The protocol achieved its goal, showing this isn't just single-center "magic." In what other groups would you like to see this protocol used? #NephJC
Chimerism is closer to being mainstream. This trial moves immune tolerance from a "Greek legend" to a reproducible strategy for select pts. The protocol achieved its goal, showing this isn't just single-center "magic." In what other groups would you like to see this protocol used? #NephJC
October 1, 2025 at 1:41 AM
T3a
Chimerism is closer to being mainstream. This trial moves immune tolerance from a "Greek legend" to a reproducible strategy for select pts. The protocol achieved its goal, showing this isn't just single-center "magic." In what other groups would you like to see this protocol used? #NephJC
Chimerism is closer to being mainstream. This trial moves immune tolerance from a "Greek legend" to a reproducible strategy for select pts. The protocol achieved its goal, showing this isn't just single-center "magic." In what other groups would you like to see this protocol used? #NephJC
Reposted by Paresh Jadav
T0c
There have been numerous developments in the field of transplantation that have improved outcomes and success rates. Today 95% of renal transplants are functional after 1 year, and 80% at five years. #NephJC
There have been numerous developments in the field of transplantation that have improved outcomes and success rates. Today 95% of renal transplants are functional after 1 year, and 80% at five years. #NephJC
October 1, 2025 at 1:10 AM
T0c
There have been numerous developments in the field of transplantation that have improved outcomes and success rates. Today 95% of renal transplants are functional after 1 year, and 80% at five years. #NephJC
There have been numerous developments in the field of transplantation that have improved outcomes and success rates. Today 95% of renal transplants are functional after 1 year, and 80% at five years. #NephJC
Reposted by Paresh Jadav
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…
-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
med.stanford.edu/hypertension/e…
-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
https://med.stanford.edu/hypertension/e…
September 25, 2025 at 8:02 AM
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…
-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
med.stanford.edu/hypertension/e…
-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
August 6, 2025 at 1:36 AM
